These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 15297790)
1. N-acetylcysteine administration during the first week of life does not improve lung function in extremely low birth weight infants. Sandberg K; Fellman V; Stigson L; Thiringer K; Hjalmarson O Biol Neonate; 2004; 86(4):275-9. PubMed ID: 15297790 [TBL] [Abstract][Full Text] [Related]
2. Randomized, double-blinded trial of low-dose dexamethasone: II. Functional residual capacity and pulmonary outcome in very low birth weight infants at risk for bronchopulmonary dysplasia. McEvoy C; Bowling S; Williamson K; McGaw P; Durand M Pediatr Pulmonol; 2004 Jul; 38(1):55-63. PubMed ID: 15170874 [TBL] [Abstract][Full Text] [Related]
3. Lung function abnormalities in infants developing bronchopulmonary dysplasia. May C; Kennedy C; Milner AD; Rafferty GF; Peacock JL; Greenough A Arch Dis Child; 2011 Nov; 96(11):1014-9. PubMed ID: 21908881 [TBL] [Abstract][Full Text] [Related]
5. Azithromycin in the extremely low birth weight infant for the prevention of bronchopulmonary dysplasia: a pilot study. Ballard HO; Anstead MI; Shook LA Respir Res; 2007 Jun; 8(1):41. PubMed ID: 17550598 [TBL] [Abstract][Full Text] [Related]
6. Is it safer to intubate premature infants in the delivery room? Aly H; Massaro AN; Patel K; El-Mohandes AA Pediatrics; 2005 Jun; 115(6):1660-5. PubMed ID: 15930230 [TBL] [Abstract][Full Text] [Related]
7. Lung function among infants born preterm, with or without bronchopulmonary dysplasia. Sanchez-Solis M; Garcia-Marcos L; Bosch-Gimenez V; Pérez-Fernandez V; Pastor-Vivero MD; Mondéjar-Lopez P Pediatr Pulmonol; 2012 Jul; 47(7):674-81. PubMed ID: 22170860 [TBL] [Abstract][Full Text] [Related]
8. Persisting hypoxaemia is an insufficient measure of adverse lung function in very immature infants. Hjalmarson O; Brynjarsson H; Nilsson S; Sandberg KL Arch Dis Child Fetal Neonatal Ed; 2014 Jul; 99(4):F257-62. PubMed ID: 24356176 [TBL] [Abstract][Full Text] [Related]
9. Changes in neonatology: comparison of two cohorts of very preterm infants (gestational age <32 weeks): the Project On Preterm and Small for Gestational Age Infants 1983 and the Leiden Follow-Up Project on Prematurity 1996-1997. Stoelhorst GM; Rijken M; Martens SE; Brand R; den Ouden AL; Wit JM; Veen S; Pediatrics; 2005 Feb; 115(2):396-405. PubMed ID: 15689337 [TBL] [Abstract][Full Text] [Related]
10. Soluble vascular endothelial growth factor receptor 1 in tracheal aspirate fluid of preterm neonates at birth may be predictive of bronchopulmonary dysplasia/chronic lung disease. Hasan J; Beharry KD; Valencia AM; Strauss A; Modanlou HD Pediatrics; 2009 Jun; 123(6):1541-7. PubMed ID: 19482766 [TBL] [Abstract][Full Text] [Related]
11. Plasma 8-isoprostane is increased in preterm infants who develop bronchopulmonary dysplasia or periventricular leukomalacia. Ahola T; Fellman V; Kjellmer I; Raivio KO; Lapatto R Pediatr Res; 2004 Jul; 56(1):88-93. PubMed ID: 15128912 [TBL] [Abstract][Full Text] [Related]
18. Role of antioxidant nutrients and lipid peroxidation in premature infants with respiratory distress syndrome and bronchopulmonary dysplasia. Falciglia HS; Johnson JR; Sullivan J; Hall CF; Miller JD; Riechmann GC; Falciglia GA Am J Perinatol; 2003 Feb; 20(2):97-107. PubMed ID: 12660915 [TBL] [Abstract][Full Text] [Related]
20. Outcome of extremely preterm infants randomized at birth to different PaCO2 targets during the first seven days of life. Thome UH; Carroll W; Wu TJ; Johnson RB; Roane C; Young D; Carlo WA Biol Neonate; 2006; 90(4):218-25. PubMed ID: 16636534 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]